Navigation Links
Commercial Medical and Pharmacy Benefit Enrollment Down in New York
Date:6/17/2009

HealthLeaders-InterStudy's Managed Market Surveyor-Rx Evaluates How Medical and Pharmacy Lives are Covered at National, State and MSA Levels

NASHVILLE, Tenn., June 17 /PRNewswire/ -- HealthLeaders-InterStudy, the leading provider of managed care market intelligence, reports that medical and pharmacy benefit enrollment in New York state declined between July 2008 and January 2009. According to data available in the newest release of Managed Market Surveyor-Rx, medical benefit enrollment declined 2.7 percent throughout the state (approximately 340,000 lives), while pharmacy benefit enrollment declined 3.6 percent (approximately 335,000 lives).

"The economy plays a large role in the enrollment declines seen in New York, particularly as the number of unemployed in the state nearly doubled in 2008," said Rebecca Waller, senior health plan analyst with HealthLeaders-InterStudy. "Overall, enrollment has decreased in New York at a higher rate than most other states."

In some states, insurers are able to retain some business lost through layoffs and business closures with sales to the individual market, but that sector is less of a factor in New York. State rules regarding medical underwriting make prices for individual designs relatively high.

The shifts seen in the New York market are just one example of the data available in Managed Market Surveyor-Rx.

"Managed Market Surveyor-Rx allows users to identify managed care enrollment trends across plans, plan type and geography to better inform resource deployment," said Russell Workman, principal director of data operations for HealthLeaders-InterStudy. "For pharmaceutical companies contracting with plans operating in New York, and throughout the country, our database provides a comprehensive assessment of a plan's market share by metropolitan statistical area (MSA) and its capacity in that market."

Why Pharmaceutical Companies Need Managed Market Surveyor-Rx

Managed Market Surveyor-Rx delivers medical and pharmacy benefit enrollment data by managed care organization and geography (national, state, MSA) to better inform strategic planning and resource allocation. Relying on primary research and HealthLeaders-InterStudy's proprietary validation methodology, Managed Market Surveyor-Rx provides the most accurate managed care database available.

About HealthLeaders-InterStudy

HealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit www.HL-ISY.com.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.


'/>"/>
SOURCE HealthLeaders-InterStudy
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AMDL CEO Featured in CEOCFO Magazine; Details Progress on DR-70 International Commercialization Strategy & Confidence in FY2009 Financial Forecast
2. Study Shows Increases in Working After 65 and Using Commercial Insurance
3. Commercial Pharmacy Benefit Enrollment Experiencing Greater Shifts in Florida than Commercial Medical Benefit Enrollment
4. Endologix Announces Full Commercial Launch of IntuiTrak Express Delivery System
5. China Sky One Medical, Inc. Welcomes Commercial Counselor from Belgium; Looks for Business Alliance with European Companies
6. ProSolv Version 4.0.2 Makes Commercial Debut at ASE
7. moksha8 Expands Alliance With Roche to Commercialize $200 Million of Products in Brazil and Mexico
8. Apieron Strengthens Senior Leadership With Commercial, Financial Appointments
9. BD and HandyLab Announce Exclusive Collaboration to Commercialize Molecular Assays
10. AMDL, Inc. Enters Into Distribution Agreements With GenWay Biotech, Inc. to Advance Commercialization of the DR-70 (FDP) Cancer Test in the US and Canada
11. Cardium Reports on New Excellarate(TM) Product Formulations to Expand Commercialization Potential Into Multiple Wound Healing Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... As an industry leader, ... webinar, they will present the line of epMotion automated liquid handling system. This ... can automate everyday pipetting tasks. , Ideal for scientists and lab technicians with ...
(Date:8/18/2017)... ... August 18, 2017 , ... Hernandez Insurance Agencies, ... communities throughout the greater DC region, is inaugurating a “New Leash On Life” ... animals and training them to be companions for veterans in need. , The ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... and financial planning services to communities in east Texas, is launching a regional ... Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has ...
(Date:8/18/2017)... Saint John, IN (PRWEB) , ... August 18, 2017 , ... ... services to communities in northwest Indiana, is campaigning in support of Campagna Academy in ... Formerly referred to as the “Hoosier Boys’ Town of Indiana,” Campagna Academy is a ...
(Date:8/18/2017)... ... ... The Golseth Agency, a Texas based insurance management and financial planning assistance provider ... organized to provide support to Christina Upchurch and her two children after the loss ... returned from out of town to find her husband passed away and their home ...
Breaking Medicine News(10 mins):
(Date:7/27/2017)... July 27, 2017  West Pharmaceutical Services, Inc. (NYSE: ... for the second-quarter 2017 and updated financial guidance for ... Second-Quarter 2017 Highlights Reported net sales ... the prior-year quarter. Net sales at constant currency (organic) ... EPS was $0.51, compared to $0.60 in the prior-year ...
(Date:7/26/2017)... SINGAPORE , July 27, 2017  Radium Medical Aesthetics, a ... LASEMD, designed to delay aging by effectively addressing several skin conditions ... the skin to become rougher and more fragile. The skin becomes ... the unavoidable exposure to the harmful UV rays from the sun ... hyperpigmentation. ...
(Date:7/26/2017)... YORK , July 26, 2017 The ... Annual Prix Galien USA Award Nominees. ... the Prix Galien Award recognizes outstanding biomedical and technology product ... To qualify, each candidate must be U.S. ... last five years and demonstrate tremendous potential to impact human ...
Breaking Medicine Technology: